Michal Levinger

Title: Michal Levinger: Innovator in Pharmaceutical Chemistry

Introduction

Michal Levinger is a notable inventor based in Nofit, Israel. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of atorvastatin calcium, a compound known for its effectiveness in lowering serum cholesterol levels. With a total of 2 patents to his name, Levinger continues to impact the pharmaceutical industry through his innovative work.

Latest Patents

Levinger's latest patents focus on the polymorphic form of atorvastatin calcium. The first patent details the new atorvastatin calcium Form V, which includes processes for preparing this new form, as well as pharmaceutical compositions and dosage forms that incorporate it. This invention is crucial for enhancing the efficacy and stability of atorvastatin calcium in medical applications.

Career Highlights

Currently, Michal Levinger is associated with Teva Pharmaceutical Industries Limited, a leading global pharmaceutical company. His work at Teva has allowed him to collaborate with other experts in the field, further advancing the development of innovative pharmaceutical solutions.

Collaborations

Some of his notable coworkers include Ari Ayalon and Sofia Roytblat. Their collaborative efforts contribute to the ongoing research and development initiatives at Teva, fostering an environment of innovation and excellence.

Conclusion

In summary, Michal Levinger is a distinguished inventor whose work in the pharmaceutical industry has led to significant advancements in cholesterol-lowering medications. His contributions, particularly in the development of atorvastatin calcium, highlight the importance of innovation in healthcare.